Skip to main content
. 2021 Sep 24;11(10):1754. doi: 10.3390/diagnostics11101754

Table 4.

LiverTox paradox: Promised data versus presented data.

Promised Data Presented Data and Gaps
Cases of iDILI with RUCAM scores [1]. Evidence is missing that RUCAM was ever used in any iDILI case included in the LiverTox database or presented on the website [2].
A complete and accurate summary of information about the clinical features of liver injury for each drug [1]. Clinical summaries were incomplete due to a lack of a diagnostic algorithm such as RUCAM to assess causality [2]. Instead, causality gradings were arbitrarily published considering the number of published case reports.
A website with comprehensive and evidence-based detailed information on iDILI cases [1]. Information was incomplete and not evidence-based, because the causality was not assessed with a robust method such as RUCAM [2] that would have assessed the exclusion of alternative causes.
A separate section on detailed information about formal CAMs such as RUCAM [1]. The section is not up to date. References are, for instance, to 2 reports of RUCAM in 1993 [15,16] and not actualized in 2016 [2] with the updated version [27], followed by additional information [28,29].
Providing standardized definitions of terms used [1]. Standard criteria of liver injury such as ALT higher than 5 × ULN and/or ALP higher than 2 × ULN [12,27] are not presented [2].

Details were derived from a published report [1], the LiverTox website [2], and Table 2. Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; CAMs, causality assessment methods; iDILI, idiosyncratic drug-induced liver injury; RUCAM, Roussel Uclaf Causality Assessment Method.